MaxCyte, Inc.
MXCT
$1.04
-$0.05-4.59%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -7.11% | -16.02% | -16.35% | -18.43% | -8.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.11% | -16.02% | -16.35% | -18.43% | -8.39% |
| Cost of Revenue | 4.81% | -29.42% | -17.22% | 2.08% | 6.70% |
| Gross Profit | -9.12% | -11.26% | -16.08% | -21.84% | -10.52% |
| SG&A Expenses | -33.96% | -39.07% | -28.58% | -2.74% | -1.69% |
| Depreciation & Amortization | -4.24% | 2.06% | 2.25% | 4.45% | -0.66% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -30.19% | -33.64% | -19.34% | 1.50% | -3.95% |
| Operating Income | 49.69% | 45.66% | 21.08% | -18.88% | -0.16% |
| Income Before Tax | 53.71% | 9.45% | -7.43% | -31.81% | -7.72% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 53.71% | 9.45% | -7.43% | -31.81% | -7.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 53.71% | 9.45% | -7.43% | -31.81% | -7.72% |
| EBIT | 49.69% | 45.66% | 21.08% | -18.88% | -0.16% |
| EBITDA | 54.12% | 49.85% | 22.80% | -20.72% | -0.31% |
| EPS Basic | 54.13% | 10.46% | -5.91% | -29.58% | -5.79% |
| Normalized Basic EPS | 54.05% | 49.84% | 20.09% | -29.64% | -5.77% |
| EPS Diluted | 54.13% | 10.46% | -5.91% | -29.58% | -5.79% |
| Normalized Diluted EPS | 54.05% | 49.84% | 20.09% | -29.64% | -5.77% |
| Average Basic Shares Outstanding | 0.87% | 1.12% | 1.43% | 1.69% | 1.79% |
| Average Diluted Shares Outstanding | 0.87% | 1.12% | 1.43% | 1.69% | 1.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |